Delcath Systems: Funding, Investors & Team (Oct 2026)
Delcath Systems specializes in the treatment of metastatic liver cancer through interventional oncology. Their distinct product, Melphalan Hydrochloride for Injection, is used in conjunction with the Delcath Hepatic Delivery System (Melphalan/HDS) to deliver targeted high-dose chemotherapy to the liver while minimizing systemic exposure.
Delcath Systems has raised $140M across 3 funding rounds on record, the most recent an undisclosed round of $35.0M announced in Sep 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Delcath Systems Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Delcath Systems Funding Rounds
Delcath Systems raised $20.0M in a Post-IPO Debt announced in Aug 2021.
1.6 years later, an undisclosed round of $85.0M was announced in Mar 2023.
6 months later, an undisclosed round of $35.0M was announced in Sep 2023.
Delcath Systems Founders and Leadership Team
Contact details for the Delcath Systems team: 2 of 2 have an email address on file.
Start 14-day free trial →Delcath Systems Funding Compared to Other Biotechnology Startups
Delcath Systems' latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Delcath Systems in Biotechnology and New York
Companies Similar to Delcath Systems
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Delcath Systems Funding FAQs
What does Delcath Systems do?
Delcath Systems specializes in the treatment of metastatic liver cancer through interventional oncology. Their distinct product, Melphalan Hydrochloride for Injection, is used in conjunction with the Delcath Hepatic Delivery System (Melphalan/HDS) to deliver targeted high-dose chemotherapy to the liver while minimizing systemic exposure.
How much funding has Delcath Systems raised?
Delcath Systems has raised $140M across 3 rounds on record. The most recent is an undisclosed round of $35.0M announced in Sep 2023.
When did Delcath Systems last raise funding?
Delcath Systems' most recent funding round on record is an undisclosed round of $35.0M, announced in Sep 2023.
Who founded Delcath Systems?
FundedIQ lists Roger Stoll (Founder) at Delcath Systems.
Who is the CEO of Delcath Systems?
Gerard Michel is listed as CEO at Delcath Systems.
Where is Delcath Systems headquartered?
Delcath Systems is based in New York, United States.
How many employees does Delcath Systems have?
Delcath Systems is in the 51-100 employee band.
How does Delcath Systems' funding compare to other Biotechnology startups?
Delcath Systems' latest round of $35.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Delcath Systems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Delcath Systems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.